A citation-based method for searching scientific literature

Helen Kühn, Leonie Kappes, Katharina Wolf, Lisa Gebhardt, Markus F Neurath, Peter Reeh, Michael J M Fischer, Andreas E Kremer. Sci Rep 2020
Times Cited: 9







List of co-cited articles
108 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Paroxysmal itch caused by gain-of-function Nav1.7 mutation.
Grazia Devigili, Roberto Eleopra, Tiziana Pierro, Raffaella Lombardi, Sara Rinaldo, Christian Lettieri, Catharina G Faber, Ingemar S J Merkies, Stephen G Waxman, Giuseppe Lauria. Pain 2014
68
55

Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus.
Qin Liu, Zongxiang Tang, Lenka Surdenikova, Seungil Kim, Kush N Patel, Andrew Kim, Fei Ru, Yun Guan, Hao-Jui Weng, Yixun Geng,[...]. Cell 2009
514
44

Efficacy of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus: A randomized, double-blind trial.
Hiromitsu Kumada, Hiroshi Miyakawa, Taro Muramatsu, Naoki Ando, Takanori Oh, Kenji Takamori, Hidetomo Nakamoto. Hepatol Res 2017
52
44

A disease mutation reveals a role for NaV1.9 in acute itch.
Juan Salvatierra, Marcelo Diaz-Bustamante, James Meixiong, Elaine Tierney, Xinzhong Dong, Frank Bosmans. J Clin Invest 2018
29
44

Peripheral and Central Mechanisms of Itch.
Xintong Dong, Xinzhong Dong. Neuron 2018
149
44

A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
Steven Fishbane, Aamir Jamal, Catherine Munera, Warren Wen, Frédérique Menzaghi. N Engl J Med 2020
105
33

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus.
Vandana S Mathur, Jayant Kumar, Paul W Crawford, Howard Hait, Thomas Sciascia. Am J Nephrol 2017
49
33

MRGPRX4 is a bile acid receptor for human cholestatic itch.
Huasheng Yu, Tianjun Zhao, Simin Liu, Qinxue Wu, Omar Johnson, Zhaofa Wu, Zihao Zhuang, Yaocheng Shi, Luxin Peng, Renxi He,[...]. Elife 2019
47
33

Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study.
Hiroo Kumagai, Toshiya Ebata, Kenji Takamori, Taro Muramatsu, Hidetomo Nakamoto, Hiromichi Suzuki. Nephrol Dial Transplant 2010
195
33

Efficacy and safety of a novel ĸ-agonist for managing intractable pruritus in dialysis patients.
Hiroo Kumagai, Toshiya Ebata, Kenji Takamori, Katsumasa Miyasato, Taro Muramatsu, Hidetomo Nakamoto, Masanao Kurihara, Tomoji Yanagita, Hiromichi Suzuki. Am J Nephrol 2012
93
33

Descending control of itch transmission by the serotonergic system via 5-HT1A-facilitated GRP-GRPR signaling.
Zhong-Qiu Zhao, Xian-Yu Liu, Joseph Jeffry, W K Ajith Karunarathne, Jin-Lian Li, Admire Munanairi, Xuan-Yi Zhou, Hui Li, Yan-Gang Sun, Li Wan,[...]. Neuron 2014
71
33

A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief.
Jun-Ho Lee, Chul-Kyu Park, Gang Chen, Qingjian Han, Rou-Gang Xie, Tong Liu, Ru-Rong Ji, Seok-Yong Lee. Cell 2014
171
33

Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial.
Sonja Ständer, Paul Kwon, Joe Hirman, Andrew J Perlman, Elke Weisshaar, Martin Metz, Thomas A Luger. J Am Acad Dermatol 2019
59
33

The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch.
Leigh A Nattkemper, Hong Liang Tey, Rodrigo Valdes-Rodriguez, Helen Lee, Nicholas K Mollanazar, Christian Albornoz, Kristen M Sanders, Gil Yosipovitch. J Invest Dermatol 2018
138
33


Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial.
R Bissonnette, K A Papp, Y Poulin, M Gooderham, M Raman, L Mallbris, C Wang, V Purohit, C Mamolo, J Papacharalambous,[...]. Br J Dermatol 2016
237
33

Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
Thomas Ruzicka, Jon M Hanifin, Masutaka Furue, Grazyna Pulka, Izabela Mlynarczyk, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Hiroki Yoshida,[...]. N Engl J Med 2017
320
33

Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
Andreas E Kremer, Job J W W Martens, Wim Kulik, Franziska Ruëff, Edith M M Kuiper, Henk R van Buuren, Karel J van Erpecum, Jurate Kondrackiene, Jesus Prieto, Christian Rust,[...]. Gastroenterology 2010
261
33

A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1.
Ferda Cevikbas, Xidao Wang, Tasuku Akiyama, Cordula Kempkes, Terhi Savinko, Attila Antal, Gabriela Kukova, Timo Buhl, Akihiko Ikoma, Joerg Buddenkotte,[...]. J Allergy Clin Immunol 2014
380
33

BAM8-22 and its receptor MRGPRX1 may attribute to cholestatic pruritus.
Babina Sanjel, Han-Joo Maeng, Won-Sik Shim. Sci Rep 2019
16
33

TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch.
Sarah R Wilson, Kristin A Gerhold, Amber Bifolck-Fisher, Qin Liu, Kush N Patel, Xinzhong Dong, Diana M Bautista. Nat Neurosci 2011
397
33

Dual action of neurokinin-1 antagonists on Mas-related GPCRs.
Ehsan Azimi, Vemuri B Reddy, Kai-Ting C Shade, Robert M Anthony, Sebastien Talbot, Paula Juliana Seadi Pereira, Ethan A Lerner. JCI Insight 2016
89
33

The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch.
Sarah R Wilson, Lydia Thé, Lyn M Batia, Katherine Beattie, George E Katibah, Shannan P McClain, Maurizio Pellegrino, Daniel M Estandian, Diana M Bautista. Cell 2013
558
33

Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.
Sonja Ständer, Barbara Böckenholt, Funda Schürmeyer-Horst, Carsten Weishaupt, Gereon Heuft, Thomas A Luger, Gudrun Schneider. Acta Derm Venereol 2009
116
22

Patients' perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study.
B Amatya, G Wennersten, K Nordlind. J Eur Acad Dermatol Venereol 2008
96
22

Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial.
Gil Yosipovitch, Sonja Ständer, Matthew B Kerby, James W Larrick, Andrew J Perlman, Edward F Schnipper, Xiaoming Zhang, Jean Y Tang, Thomas Luger, Martin Steinhoff. J Am Acad Dermatol 2018
73
22

UVB- and NGF-induced cutaneous sensitization in humans selectively augments cowhage- and histamine-induced pain and evokes mechanical hyperknesis.
Hjalte H Andersen, Silvia Lo Vecchio, Jesper Elberling, Gil Yosipovitch, Lars Arendt-Nielsen. Exp Dermatol 2018
10
22

Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors.
William T Ralvenius, Elena Neumann, Martina Pagani, Mario A Acuña, Hendrik Wildner, Dietmar Benke, Nina Fischer, Ana Rostaher, Simon Schwager, Michael Detmar,[...]. Nat Commun 2018
23
22

Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.
Yoko Murata, Michael Song, Hisayuki Kikuchi, Katsuya Hisamichi, Xie L Xu, Andrew Greenspan, Mai Kato, Chiun-Fang Chiou, Takeshi Kato, Cynthia Guzzo,[...]. J Dermatol 2015
85
22

Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice.
Sarah E Ross, Alan R Mardinly, Alejandra E McCord, Jonathan Zurawski, Sonia Cohen, Cynthia Jung, Linda Hu, Stephanie I Mok, Anar Shah, Erin M Savner,[...]. Neuron 2010
292
22

Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy.
Sonja Ständer, Dorothee Siepmann, Ilka Herrgott, Cord Sunderkötter, Thomas A Luger. PLoS One 2010
191
22


Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial.
David M Pariser, Jerry Bagel, Mark Lebwohl, Gil Yosipovitch, Elaine Chien, Mary C Spellman. J Am Acad Dermatol 2020
25
22

Itch: From mechanism to (novel) therapeutic approaches.
Gil Yosipovitch, Jordan Daniel Rosen, Takashi Hashimoto. J Allergy Clin Immunol 2018
119
22

Protease-activated receptors and itch.
Tasuku Akiyama, Ethan A Lerner, E Carstens. Handb Exp Pharmacol 2015
28
22

Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial.
Zbigniew Zylicz, Malgorzata Krajnik, Adriaan Alistar van Sorge, Massimo Costantini. J Pain Symptom Manage 2003
110
22

Sertraline as a first-line treatment for cholestatic pruritus.
Marlyn J Mayo, Iorna Handem, Sandra Saldana, Heidi Jacobe, Yonas Getachew, A John Rush. Hepatology 2007
173
22

Clinical practice. Chronic pruritus.
Gil Yosipovitch, Jeffrey D Bernhard. N Engl J Med 2013
233
22

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses.
Kenya Kamimura, Takeshi Yokoo, Hiroteru Kamimura, Akira Sakamaki, Satoshi Abe, Atsunori Tsuchiya, Masaaki Takamura, Hirokazu Kawai, Satoshi Yamagiwa, Shuji Terai. PLoS One 2017
32
22

Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
F H Wolfhagen, E Sternieri, W C Hop, G Vitale, M Bertolotti, H R Van Buuren. Gastroenterology 1997
217
22

PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models.
Travis P Barr, Chris Garzia, Srijoy Guha, Elizabeth K Fletcher, Nga Nguyen, Adam J Wieschhaus, Lluis Ferrer, Lidija Covic, Athan Kuliopulos. J Invest Dermatol 2019
34
22

Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study.
Daniele Santini, Bruno Vincenzi, Francesco M Guida, Marco Imperatori, Gaia Schiavon, Olga Venditti, Anna M Frezza, Pierpaolo Berti, Giuseppe Tonini. Lancet Oncol 2012
69
22

Targeted treatment of pruritus: a look into the future.
H L Tey, G Yosipovitch. Br J Dermatol 2011
62
22

Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
Björn Wikström, Ryszard Gellert, Søren D Ladefoged, Yasuaki Danda, Masahiko Akai, Kaoru Ide, Midori Ogasawara, Yoshiharu Kawashima, Koki Ueno, Akio Mori,[...]. J Am Soc Nephrol 2005
198
22

Randomised crossover trial of naltrexone in uraemic pruritus.
G Peer, S Kivity, O Agami, E Fireman, D Silverberg, M Blum, A laina. Lancet 1996
206
22

Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU).
Athanasios Tsianakas, Claudia Zeidler, Claudia Riepe, Matthias Borowski, Caroline Forner, Joachim Gerss, Martin Metz, Petra Staubach, Ulrike Raap, Martin Kaatz,[...]. Acta Derm Venereol 2019
28
22

Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients.
Steven Fishbane, Vandana Mathur, Michael J Germain, Shayan Shirazian, Sarbani Bhaduri, Catherine Munera, Robert H Spencer, Frédérique Menzaghi. Kidney Int Rep 2020
29
22


Aprepitant as an antipruritic agent?
Arnaud Duval, Louis Dubertret. N Engl J Med 2009
90
22

Butorphanol for treatment of intractable pruritus.
Aerlyn G Dawn, Gil Yosipovitch. J Am Acad Dermatol 2006
120
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.